XOMA to Present at Two Upcoming Investor Conferences
November 12 2015 - 03:00PM
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and
development of therapeutic antibodies, announced today members of
its executive team will present at two upcoming investor
conferences. The details are as follows:
- Jefferies Autumn 2015 Global Healthcare Conference London on
Thursday, November 19 at 3:20p.m. GMT (7:20 a.m. PT)
- 27th Annual Piper Jaffray Healthcare Conference on Tuesday,
December 1 at 10:00 a.m. ET (7:00a.m. PT)
Live audio webcasts of the presentations can be accessed through
the Investors and Media section of XOMA's website at
http://investors.xoma.com/events.cfm. Archived versions of the
webcast will be available via replay for 30 days following the
presentations.
About XOMA Corporation
XOMA Corporation is a leader in the discovery and development of
therapeutic antibodies. The Company's innovative product candidates
result from the Company's expertise in developing ground-breaking
monoclonal antibodies, including allosteric antibodies, which have
created new opportunities to potentially treat a wide range of
human diseases. XOMA's scientific research has produced a portfolio
of 6 endocrine assets, each of which have the opportunity to
address multiple indications. The Company's lead product candidate,
XOMA 358, is an allosteric monoclonal antibody that reduces insulin
receptor activity, which could have a major effect on the treatment
of hyperinsulinism. The Company recently initiated Phase 2
development activities for XOMA 358. Additionally, XOMA is
developing gevokizumab (IL-1 beta modulating antibody) in an
ongoing Phase 3 program enrolling patients with pyoderma
gangrenosum, a rare ulcerative skin condition. For more
information, visit www.xoma.com.
CONTACT: XOMA Contacts:
Company and Investor Contacts:
Ashleigh Barreto
510-204-7482
barreto@xoma.com
Juliane Snowden
The Oratorium Group, LLC
jsnowden@oratoriumgroup.com
Media Contact:
Ryan Flinn, W2O Group
415-946-1059
rflinn@w2ogroup.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Feb 2024 to Mar 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2023 to Mar 2024